Toth Financial Advisory Corp Raises Stake in The Clorox Company (NYSE:CLX)

Toth Financial Advisory Corp boosted its position in The Clorox Company (NYSE:CLX) by 5.4% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,103 shares of the company’s stock after purchasing an additional 567 shares during the quarter. Toth Financial Advisory Corp’s holdings in Clorox were worth $1,809,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently added to or reduced their stakes in CLX. GoalVest Advisory LLC purchased a new position in shares of Clorox in the 1st quarter worth about $31,000. First Foundation Advisors bought a new position in shares of Clorox during the first quarter valued at about $31,000. Innealta Capital LLC purchased a new stake in Clorox in the 2nd quarter worth approximately $30,000. Trifecta Capital Advisors LLC boosted its holdings in Clorox by 139.8% in the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after acquiring an additional 130 shares in the last quarter. Finally, Quarry LP increased its position in shares of Clorox by 99.1% during the second quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after buying an additional 114 shares during the period. Institutional investors own 78.53% of the company’s stock.

Insider Activity

In related news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the transaction, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.51% of the company’s stock.

Clorox Stock Down 0.8 %

NYSE CLX traded down $1.25 during trading on Monday, hitting $160.71. The company’s stock had a trading volume of 227,091 shares, compared to its average volume of 1,225,699. The company has a market cap of $19.96 billion, a PE ratio of 83.92, a P/E/G ratio of 3.19 and a beta of 0.41. The company has a debt-to-equity ratio of 5.04, a current ratio of 1.03 and a quick ratio of 0.63. The business’s 50 day simple moving average is $159.28 and its 200-day simple moving average is $145.14. The Clorox Company has a fifty-two week low of $114.68 and a fifty-two week high of $169.09.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, August 1st. The company reported $1.82 EPS for the quarter, topping the consensus estimate of $1.54 by $0.28. The business had revenue of $1.90 billion during the quarter, compared to the consensus estimate of $1.97 billion. Clorox had a net margin of 3.95% and a return on equity of 281.12%. On average, equities analysts anticipate that The Clorox Company will post 6.64 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 3.04%. The ex-dividend date of this dividend is Wednesday, October 23rd. Clorox’s dividend payout ratio is presently 252.85%.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on CLX. Wells Fargo & Company lowered their price objective on Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a research note on Wednesday, July 10th. JPMorgan Chase & Co. raised their target price on Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research report on Friday, October 11th. Barclays boosted their price objective on shares of Clorox from $130.00 to $137.00 and gave the company an “underweight” rating in a research report on Friday, October 11th. Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and lifted their price target for the company from $174.00 to $187.00 in a report on Tuesday, October 1st. Finally, DA Davidson reaffirmed a “neutral” rating and issued a $153.00 price objective on shares of Clorox in a research note on Friday, September 6th. Six investment analysts have rated the stock with a sell rating, nine have issued a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Clorox currently has a consensus rating of “Hold” and a consensus price target of $150.14.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.